The Defense Health Agency awarded a $744,997 Project Grant to the University of Queensland in Australia under the Military Medical Research and Development program (CFDA 12.420). This grant, titled "DISCOVERING THERAPEUTIC VULNERABILITIES OF CIRCULATING MELANOMA CLUSTERS," provides funding for the university to conduct cutting-edge biomedical research on melanoma from June 1, 2024 through May 31, 2027. The University of Queensland, a leading research institution in Australia, has an extensive track record of collaborating with U.S. federal agencies on defense, healthcare, and scientific research projects. Through this grant, the university will investigate new therapeutic approaches for treating melanoma, a type of skin cancer, with a focus on circulating melanoma clusters. The research aims to identify vulnerabilities in these cancer cell clusters that could be targeted with innovative interventions. This federally funded project contributes to the Military Medical Research and Development program's broader goals of advancing medical solutions for military personnel and the general public through innovative biomedical research.
Generated 3/4/25, 6:58 AM